Latest Clinical trial Stories
SAN DIEGO, Feb. 11, 2013 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that it has initiated dosing in a thorough QT/QTc study (TQT study) of ANX-188. Brian M. Culley, Chief Executive Officer, said: "Consistent with our guidance from October 2011 and our commitment to FDA, we have initiated this study before the end of the first quarter. We were pleased with the discussion we had with the Agency on the study protocol and our agreement on the...
WAYNE, N.J., Feb. 11, 2013 /PRNewswire/ -- Bayer HealthCare today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for riociguat, an investigational compound for the treatment of pulmonary arterial hypertension (PAH) and persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) after surgical treatment or inoperable CTEPH. "Bayer is submitting an NDA for riociguat for the treatment...
Dr. Ben Goldacre will keynote the PhUSE Annual Conference in Brussels, Belgium in October 2013. Dr. Goldacre will speak about how flaws in the planning, conduct and publication of studies conducted by the Pharmaceutical industry can harm the lives of patients. Brussels, Belgium (PRWEB) February 07, 2013 PhUSE, a non-profit, volunteer-supported, community of professionals who are passionate about advancement of clinical information, is proud to announce that Dr. Ben Goldacre will present...
LIEGE, Belgium, February 7, 2013 /PRNewswire/ -- The American scientific journal NEUROLOGY publishes the positive results of the PREMICE clinical study on the effectiveness and safety of the CEFALY(R) medical device in the prevention of migraine. NEUROLOGY (official journal of the American Academy of Neurology, the number one among the most-cited journals worldwide in the field of neurology) is publishing the results of the multi-centre PREMICE clinical study...
An international collaboration of researchers from the U.S. Army Medical Research and Materiel Command (USAMRMC), Tunisia and France has demonstrated a high cure rate and remarkably few side effects in treating patients with cutaneous leishmaniasis (CL) with an investigational antibiotic cream. CL is a parasitic disease that causes disfiguring lesions, with 350 million people at risk worldwide and 1.5 million new cases annually, including U.S. military personnel serving abroad and the...
ROCHESTER, N.Y., Feb. 7, 2013 /PRNewswire/ -- Bio-Optronics, the maker of Clinical Conductor Site CTMS, is proud to unveil its first software release of 2013. Over the course of the past several months, Bio-Optronics has been working to incorporate user-requested and general enhancements into the already highly comprehensive Clinical Conductor CTMS application. This release launches a new look and streamlined workflow for the application. Application enhancements include a...
SAN DIEGO, Feb. 6, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview at two upcoming investor conferences at The Waldorf Astoria in New York City: 15th Annual BIO CEO & Investor ConferencePresentation: February 12, 2013, at 1:30 p.m. Eastern Time (10:30 a.m. Pacific Time) Leerink Swann Global Healthcare Conference Presentation: February 13, 2013, at 2:30 p.m. Eastern Time (11:30 a.m....
BURLINGTON, Mass., Feb. 5, 2013 /PRNewswire/ -- inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, today announced that, at a ceremony in London, inVentiv Health Clinical was named "Clinical Company of the Year" by PharmaTimes. "This award recognizes the tremendous value that inVentiv Health Clinical brings to clients," said Paul Meister, Chief Executive Officer of inVentiv Health. "By linking our Clinical...
CLEVELAND, Feb. 5, 2013 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced Chris Wilke, DATATRAK's Chief Technology Officer, was elected as the CDISC Advisory Board's (CAB) Chair-Elect. (Logo: http://photos.prnewswire.com/prnh/20130107/CL38347LOGO) "We are very pleased to have Chris Wilke as a member of the CDISC...
Research Dynamics Consulting Group, a full service Contract Research Organization (CRO), and ClinROC, LLC, a consulting company of Ophthalmology experts, are announcing a strategic alliance to provide clinical research and product development services for the industry. Rochester, NY, USA (PRWEB) February 04, 2013 Ophthalmology has been shown to be one of the fastest growing fields of clinical research and this alliance aims to meet those needs by providing fast and accurate clinical trial...
